# FDA Inspection 1220606 - National Institutes of Health IRB - October 11, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/national-institutes-of-health-irb/2a360852-f1b6-42c8-a580-f092ac961b51
Source feed: FDA_Inspections

> FDA Inspection 1220606 for National Institutes of Health IRB on October 11, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1220606
- Company Name: National Institutes of Health IRB
- Inspection Date: 2023-10-11
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1220606 - 2023-10-11](https://www.globalkeysolutions.net/records/fda_inspections/national-institutes-of-health-irb/9b94acc5-9459-431c-94f5-131a5010fddb)
- [FDA Inspection 1220606 - 2023-10-11](https://www.globalkeysolutions.net/records/fda_inspections/national-institutes-of-health-irb/fb633f57-0c3d-49eb-991c-d2c65745c106)
- [FDA Inspection 1046908 - 2018-01-25](https://www.globalkeysolutions.net/records/fda_inspections/national-institutes-of-health-irb/9880ab31-263c-49e3-972e-dabc9410e17e)

Company: https://www.globalkeysolutions.net/companies/national-institutes-of-health-irb/60ed3db6-f6bf-406d-b90f-b4be0204ecaf

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c